Philip Morris International Inc. (PMI) receives Investment Canada approval for Rothmans offer

    NEW YORK, Sept. 12 /CNW/ - Philip Morris International Inc.
(NYSE/Euronext Paris: PM) today received Ministry of Industry approval
pursuant to the Investment Canada Act in connection with the company's
proposed acquisition of Rothmans Inc. (TSX: ROC).
    The issuance of this approval satisfies the last remaining regulatory
condition to the company's acquisition offer dated August 7, 2008. In
connection with the determination of net benefit, the company provided certain
undertakings, including pledges to continue to operate Rothmans, Benson &
Hedges Inc.'s current manufacturing facilities in Canada, invest in their
modernization and provide minimum employment assurances.
    The company's offer to acquire Rothmans is open for acceptance until
11:59 p.m. (Vancouver time), at the end of September 16, 2008, unless extended
or withdrawn by the company.
    The offer documents are available on the SEDAR website at,
under the SEDAR profile for Rothmans Inc.

    About Philip Morris International

    Philip Morris International (PMI) (NYSE/Euronext Paris: PM) is the
leading international tobacco company, with seven of the world's top 15 brands
including Marlboro, the number one cigarette brand worldwide. PMI has more
than 75,000 employees and its products are sold in over 160 countries. The
Company held a 15.6% share of the international cigarette market outside of
the United States in 2007. For more information, see

For further information:

For further information: Philip Morris International Inc., Investor
Relations: New York: (917) 663-2233, Lausanne: +41 (0)58 242 4666,

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890